- Home
- RLMD vs CXAI Comparison
RLMD vs CXAI Comparison
Compare RLMD & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- CXAI
- Stock Information
- Founded
- RLMD 2004
- CXAI N/A
- Country
- RLMD United States
- CXAI United States
- Employees
- RLMD N/A
- CXAI N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- CXAI EDP Services
- Sector
- RLMD Health Care
- CXAI Technology
- Exchange
- RLMD Nasdaq
- CXAI Nasdaq
- Market Cap
- RLMD 22.0M
- CXAI 22.4M
- IPO Year
- RLMD N/A
- CXAI N/A
- Fundamental
- Price
- RLMD $0.83
- CXAI $1.01
- Analyst Decision
- RLMD Hold
- CXAI
- Analyst Count
- RLMD 4
- CXAI 0
- Target Price
- RLMD $4.25
- CXAI N/A
- AVG Volume (30 Days)
- RLMD 840.1K
- CXAI 725.7K
- Earning Date
- RLMD 05-12-2025
- CXAI 05-20-2025
- Dividend Yield
- RLMD N/A
- CXAI N/A
- EPS Growth
- RLMD N/A
- CXAI N/A
- EPS
- RLMD N/A
- CXAI N/A
- Revenue
- RLMD N/A
- CXAI $6,548,000.00
- Revenue This Year
- RLMD N/A
- CXAI N/A
- Revenue Next Year
- RLMD N/A
- CXAI $60.00
- P/E Ratio
- RLMD N/A
- CXAI N/A
- Revenue Growth
- RLMD N/A
- CXAI N/A
- 52 Week Low
- RLMD $0.24
- CXAI $0.76
- 52 Week High
- RLMD $4.47
- CXAI $3.76
- Technical
- Relative Strength Index (RSI)
- RLMD 72.41
- CXAI 44.83
- Support Level
- RLMD $0.65
- CXAI $0.94
- Resistance Level
- RLMD $0.77
- CXAI $1.08
- Average True Range (ATR)
- RLMD 0.10
- CXAI 0.10
- MACD
- RLMD 0.02
- CXAI -0.01
- Stochastic Oscillator
- RLMD 86.00
- CXAI 14.23
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.